FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2959202338> ?p ?o ?g. }

• W2959202338 abstract "People who inject drugs (PWID) are disproportionally affected by the hepatitis C virus (HCV) infection. In the Netherlands, active HCV transmission in PWID has practically been halted but uptake of HCV testing and linkage to care remains insufficient in this risk group. A national HCV in Addiction Care (HAC) quality improvement project based on the Breakthrough methodology (i.e. Breakthrough project) aimed to secure proper linkage to care in PWID by introducing local HCV healthcare screening and treatment pathways in addiction care units. To qualitatively appraise the local HCV healthcare pathways; to evaluate the yield in terms of number of PWID screened, diagnosed, referred, and treated; and to identify best practices and barriers to successful participation in the HAC Breakthrough project. Between 2013 and 2016, 12 units of addiction care centers throughout the Netherlands participated in two series of a HAC Breakthrough project. Local multidisciplinary teams created HCV healthcare pathways. Quality assessment of HCV healthcare pathways was performed retrospectively and data on screening results was collected. In-depth interviews were conducted to elucidate best practices and essential elements for successful participation. In total, six HCV healthcare pathways were submitted by ten teams of which 83% was judged to be of “good” or “sufficient” quality. Uptake of HCV-antibody screening was 40% (N = 487/1219) and uptake of HCV-RNA in HCV-antibody positives was 59% (N = 107/181). The project resulted in 76 (6%) newly detected cases of persistent HCV viremia. Of all HCV-RNA positives, 92% was referred to a hepatitis treatment center. In 39% (N = 27/70) of those referred, treatment initiation was documented and 82% (N = 22/27) achieved a sustained virological response. Teams identified several best practices including motivational counseling training, oral swabs for anti-HCV testing, facilitating complementary HCV RNA testing, and supervised hospital visits. The HAC Breakthrough project has brought about good quality HCV healthcare pathways in the majority of participating addiction care centers and has successfully linked PWID with ongoing HCV viremia to care. Uptake of HCV screening and treatment after referral were identified as the main gaps to be closed in the HCV cascade of care to achieve final HCV elimination in Dutch PWID (i.e. micro-elimination)." @default.
• W2959202338 created "2019-07-23" @default.
• W2959202338 creator A5008519282 @default.
• W2959202338 creator A5017091744 @default.
• W2959202338 creator A5034359980 @default.
• W2959202338 creator A5035479597 @default.
• W2959202338 creator A5045561980 @default.
• W2959202338 creator A5048394409 @default.
• W2959202338 creator A5072912407 @default.
• W2959202338 date "2019-07-15" @default.
• W2959202338 modified "2023-10-12" @default.
• W2959202338 title "Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study" @default.
• W2959202338 cites W1502211039 @default.
• W2959202338 cites W1978701515 @default.
• W2959202338 cites W1984413237 @default.
• W2959202338 cites W1985301248 @default.
• W2959202338 cites W1987584396 @default.
• W2959202338 cites W1999099454 @default.
• W2959202338 cites W2006309458 @default.
• W2959202338 cites W2035655657 @default.
• W2959202338 cites W2061792651 @default.
• W2959202338 cites W2066124462 @default.
• W2959202338 cites W2086887894 @default.
• W2959202338 cites W2091570052 @default.
• W2959202338 cites W2092368342 @default.
• W2959202338 cites W2098036216 @default.
• W2959202338 cites W2164227241 @default.
• W2959202338 cites W2166975035 @default.
• W2959202338 cites W2169626785 @default.
• W2959202338 cites W2250055388 @default.
• W2959202338 cites W2275861154 @default.
• W2959202338 cites W2315381719 @default.
• W2959202338 cites W2399447949 @default.
• W2959202338 cites W2622365485 @default.
• W2959202338 cites W2744191372 @default.
• W2959202338 cites W2745368132 @default.
• W2959202338 cites W2912954134 @default.
• W2959202338 cites W2943308876 @default.
• W2959202338 doi "https://doi.org/10.1186/s12954-019-0316-4" @default.
• W2959202338 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6631626" @default.
• W2959202338 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31307470" @default.
• W2959202338 hasPublicationYear "2019" @default.
• W2959202338 type Work @default.
• W2959202338 sameAs 2959202338 @default.
• W2959202338 citedByCount "5" @default.
• W2959202338 countsByYear W29592023382021 @default.
• W2959202338 countsByYear W29592023382022 @default.
• W2959202338 countsByYear W29592023382023 @default.
• W2959202338 crossrefType "journal-article" @default.
• W2959202338 hasAuthorship W2959202338A5008519282 @default.
• W2959202338 hasAuthorship W2959202338A5017091744 @default.
• W2959202338 hasAuthorship W2959202338A5034359980 @default.
• W2959202338 hasAuthorship W2959202338A5035479597 @default.
• W2959202338 hasAuthorship W2959202338A5045561980 @default.
• W2959202338 hasAuthorship W2959202338A5048394409 @default.
• W2959202338 hasAuthorship W2959202338A5072912407 @default.
• W2959202338 hasBestOaLocation W29592023381 @default.
• W2959202338 hasConcept C118552586 @default.
• W2959202338 hasConcept C138816342 @default.
• W2959202338 hasConcept C155164915 @default.
• W2959202338 hasConcept C159047783 @default.
• W2959202338 hasConcept C159110408 @default.
• W2959202338 hasConcept C160735492 @default.
• W2959202338 hasConcept C162324750 @default.
• W2959202338 hasConcept C2522874641 @default.
• W2959202338 hasConcept C2776408679 @default.
• W2959202338 hasConcept C2776455275 @default.
• W2959202338 hasConcept C48856860 @default.
• W2959202338 hasConcept C50522688 @default.
• W2959202338 hasConcept C512399662 @default.
• W2959202338 hasConcept C71924100 @default.
• W2959202338 hasConceptScore W2959202338C118552586 @default.
• W2959202338 hasConceptScore W2959202338C138816342 @default.
• W2959202338 hasConceptScore W2959202338C155164915 @default.
• W2959202338 hasConceptScore W2959202338C159047783 @default.
• W2959202338 hasConceptScore W2959202338C159110408 @default.
• W2959202338 hasConceptScore W2959202338C160735492 @default.
• W2959202338 hasConceptScore W2959202338C162324750 @default.
• W2959202338 hasConceptScore W2959202338C2522874641 @default.
• W2959202338 hasConceptScore W2959202338C2776408679 @default.
• W2959202338 hasConceptScore W2959202338C2776455275 @default.
• W2959202338 hasConceptScore W2959202338C48856860 @default.
• W2959202338 hasConceptScore W2959202338C50522688 @default.
• W2959202338 hasConceptScore W2959202338C512399662 @default.
• W2959202338 hasConceptScore W2959202338C71924100 @default.
• W2959202338 hasIssue "1" @default.
• W2959202338 hasLocation W29592023381 @default.
• W2959202338 hasLocation W29592023382 @default.
• W2959202338 hasLocation W29592023383 @default.
• W2959202338 hasLocation W29592023384 @default.
• W2959202338 hasLocation W29592023385 @default.
• W2959202338 hasOpenAccess W2959202338 @default.
• W2959202338 hasPrimaryLocation W29592023381 @default.
• W2959202338 hasRelatedWork W1968534733 @default.
• W2959202338 hasRelatedWork W2003774060 @default.
• W2959202338 hasRelatedWork W2099834937 @default.
• W2959202338 hasRelatedWork W2104477017 @default.
• W2959202338 hasRelatedWork W2398182445 @default.
• W2959202338 hasRelatedWork W2810424448 @default.
• W2959202338 hasRelatedWork W2944115420 @default.

• next